Insider · CIK 0001271244
Richard Christopher
Files at LEXX (Lexaria Bioscience Corp.). First filing Dec 3, 2024, latest Jul 30, 2025.
In brief
Richard Christopher files SEC Form 4 as CEO and director at LEXX (Lexaria Bioscience Corp.). Since Dec 3, 2024, Richard Christopher has reported 2 open-market buys worth $132k and 0 open-market sells worth $0, the latest filed on Jul 30, 2025.
A track record needs three past buys with six months of prices behind them; Richard Christopher has 0, so none is measured yet.
The newest scored trade: bought $14k of LEXX on Jul 29, 2025, filed Jul 30, 2025, scored 64 (notable).
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
LEXX: Lexaria Bioscience Corp.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 64Notable | Lexaria Bioscience Corp. | $14k 15,000 shares | +30% | +9% from low-75% from high | |
| 43Moderate | LEXXbuy Lexaria Bioscience Corp. | $118k 50,000 shares | - | - |
Transactions
Every row this insider has filed, 4 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jul 29, 2025 | LEXX Lexaria Bioscience Corp. | POpen-market purchase common shares | +15,000 | $0.91 | $14k | 65,000 | Jul 30, 2025 |
| May 15, 2025 | LEXX Lexaria Bioscience Corp. | AGrant or award Stock Optionsderivative | +150,000 | $0.00 | $0 | 350,000 | May 16, 2025 |
| Dec 2, 2024 | LEXX Lexaria Bioscience Corp. | POpen-market purchase common shares | +22,828 | $2.24 | $51k | 22,828 | Dec 3, 2024 |
| Dec 3, 2024 | LEXX Lexaria Bioscience Corp. | POpen-market purchase common shares | +27,172 | $2.47 | $67k | 50,000 | Dec 3, 2024 |
Questions about Richard Christopher
Answered from the filings on this page, as of the latest one.
Is Richard Christopher buying or selling?
Not in the last 12 months. Richard Christopher's latest open-market trade on SEC Form 4 was bought $14k of LEXX on Jul 29, 2025.
How did Richard Christopher's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Richard Christopher has 0.
Where does Richard Christopher file Form 4?
Richard Christopher has filed Form 4 at LEXX (Lexaria Bioscience Corp.) as Chief Executive Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.